Nick J. Reynolds

Framlington Place
Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 137 publications

Receptor specificity and translational considerations for laminin-mimetic Caf1 scaffolds: reply from authors.

Receptor specificity and translational considerations for laminin-mimetic Caf1 scaffolds: reply from authors.

Journal: The British journal of dermatology

Published: July 28, 2026

Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.

Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: March 29, 2026

Rapid remission of isolated orofacial granulomatosis with upadacitinib.

Rapid remission of isolated orofacial granulomatosis with upadacitinib.

Journal: Clinical and experimental dermatology

Published: February 25, 2026

Serious infection risk with systemic treatments for psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Serious infection risk with systemic treatments for psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Journal: The British journal of dermatology

Published: February 24, 2026

Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Journal: Clinical and translational science

Published: February 18, 2026

Healthcare resource use, costs and health-related quality of life in the UK-Irish Atopic eczema Systemic Therapy Register (A-STAR): a pilot study.

Healthcare resource use, costs and health-related quality of life in the UK-Irish Atopic eczema Systemic Therapy Register (A-STAR): a pilot study.

Journal: Skin health and disease

Published: February 17, 2026

Serious infection risk of certolizumab compared with other systemic therapies in women with psoriasis.

Serious infection risk of certolizumab compared with other systemic therapies in women with psoriasis.

Journal: The British journal of dermatology

Published: February 16, 2026

Serious infections in children and young people with psoriasis on systemic treatments.

Serious infections in children and young people with psoriasis on systemic treatments.

Journal: The British journal of dermatology

Published: February 11, 2026

Serious infection risk in people treated with infliximab for severe psoriasis.

Serious infection risk in people treated with infliximab for severe psoriasis.

Journal: The British journal of dermatology

Published: November 18, 2025

Engineered Caf1 Constructs Encoding Laminin-332 Motifs: A Novel Approach for Enhanced Cutaneous Wound Healing.

Engineered Caf1 Constructs Encoding Laminin-332 Motifs: A Novel Approach for Enhanced Cutaneous Wound Healing.

Journal: The British journal of dermatology

Published: October 05, 2025

Gene-environment interaction analysis in atopic eczema: evidence from large population datasets and modelling in vitro.

Gene-environment interaction analysis in atopic eczema: evidence from large population datasets and modelling in vitro.

Journal: medRxiv : the preprint server for health sciences

Published: September 15, 2025

Dermal papillary fibroblasts promote persistent granulation tissue formation in junctional epidermolysis bullosa.

Dermal papillary fibroblasts promote persistent granulation tissue formation in junctional epidermolysis bullosa.

Journal: EMBO molecular medicine

Published: July 04, 2025

Showing 1-12 of 137

Last Updated: 09/26/2026